ArticleTherapeutic advances in medical oncology2025

Treatment options for EGFR mutation-positive NSCLC patients with leptomeningeal metastases after third-generation TKI resistance: a retrospective real-world study.

Wenhua Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.